🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to investigate the efficacy and safety of the "cap...
Status
Active Not Recruiting
Location
SunYat-senU
Start Date
2023-04-28
Trial ID
NCT05869227
Treatments Being Tested
This multicenter, randomized, double-blind phase III study intends to recru...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2022-02-10
Trial ID
NCT05180734
Treatments Being Tested
This is a prospective, randomized, placebo-controlled, double-blind, multic...
Status
Active Not Recruiting
Location
Qinhuai Medical Area, General Hospital of PLA Eastern Theater Command
Start Date
2020-06-29
Trial ID
NCT04523493
Treatments Being Tested
A mucosal melanoma postoperative adjuvant treatment of multicenter, randomi...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2020-05-30
Trial ID
NCT04462965
Treatments Being Tested
This study plans to enroll 156 patients aged 18-75, who will be randomly di...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-18
Trial ID
NCT07191405
Treatments Being Tested
This is a Phase III, prospective, randomized, three-arm, double-blind, plac...
Status
Recruiting
Location
Zhongshan Hospital affiliated to Fudan University
Start Date
2023-06-19
Trial ID
NCT05342194
This is a randomized, placebo-controlled, multi-center, double blinded, Pha...
Status
Completed
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2018-10-18
Trial ID
NCT03581786
Treatments Being Tested
This is a randomized Phase II trial to study the effectiveness and toxicity...
Status
Unknown
Location
Sun Yat-sen Universitty Cancer Center
Start Date
2019-12-08
Trial ID
NCT03925090
Treatments Being Tested
The Study is a Phase 3, randomized, three-arm, double-blind, placebo-contro...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2023-11-15
Trial ID
NCT06095583
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, multi-center, phase...
Status
Completed
Location
Shanghai Chest Hospital
Start Date
2020-04-07
Trial ID
NCT04158440